Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R D Wasnich

Showing results (111-120 of 117) with videos related to

Pageof 12
Sort By:
You have reached the last page of results.This site can display upto 117 results.
Clinical Therapeutics|November 26, 1998
Evidence that increased calcium intake does not prevent early postmenopausal bone lossD J Hosking, P D Ross, D E Thompson, et al.
The American Journal of Medicine|December 1, 1993
Four-year study of intermittent cyclic etidronate treatment of postmenopausal osteoporosis: three years of blinded therapy followed by one year of open therapyS T Harris, N B Watts, R D Jackson, et al.
The New England Journal of Medicine|July 12, 1990
Intermittent cyclical etidronate treatment of postmenopausal osteoporosisN B Watts, S T Harris, H K Genant, et al.
The Journal of Clinical Endocrinology and Metabolism|September 22, 2000
Skeletal benefits of alendronate: 7-year treatment of postmenopausal osteoporotic women. Phase III Osteoporosis Treatment Study GroupR P Tonino, P J Meunier, R Emkey, et al.
The Journal of Clinical Endocrinology and Metabolism|April 19, 2000
Alendronate in early postmenopausal women: effects on bone mass during long-term treatment and after withdrawal. Alendronate Osteoporosis Prevention Study GroupP Ravn, S R Weiss, J A Rodriguez-Portales, et al.
The American Journal of Medicine|January 16, 1998
Cyclical etidronate in the treatment of postmenopausal osteoporosis: efficacy and safety after seven years of treatmentP D Miller, N B Watts, A A Licata, et al.
Seminars in Arthritis and Rheumatism|June 1, 1996
Clinical utility of bone mass measurements in adults: consensus of an international panel. The Society for Clinical DensitometryP D Miller, S L Bonnick, C J Rosen, et al.
Pageof 12

Showing results (111-120 of 117) with videos related to

Sort By:
Pageof 12
You have reached the last page of results.This site can display upto 117 results.
Clinical Therapeutics|November 26, 1998
Evidence that increased calcium intake does not prevent early postmenopausal bone lossD J Hosking, P D Ross, D E Thompson, et al.
The American Journal of Medicine|December 1, 1993
Four-year study of intermittent cyclic etidronate treatment of postmenopausal osteoporosis: three years of blinded therapy followed by one year of open therapyS T Harris, N B Watts, R D Jackson, et al.
The New England Journal of Medicine|July 12, 1990
Intermittent cyclical etidronate treatment of postmenopausal osteoporosisN B Watts, S T Harris, H K Genant, et al.
The Journal of Clinical Endocrinology and Metabolism|September 22, 2000
Skeletal benefits of alendronate: 7-year treatment of postmenopausal osteoporotic women. Phase III Osteoporosis Treatment Study GroupR P Tonino, P J Meunier, R Emkey, et al.
The Journal of Clinical Endocrinology and Metabolism|April 19, 2000
Alendronate in early postmenopausal women: effects on bone mass during long-term treatment and after withdrawal. Alendronate Osteoporosis Prevention Study GroupP Ravn, S R Weiss, J A Rodriguez-Portales, et al.
The American Journal of Medicine|January 16, 1998
Cyclical etidronate in the treatment of postmenopausal osteoporosis: efficacy and safety after seven years of treatmentP D Miller, N B Watts, A A Licata, et al.
Seminars in Arthritis and Rheumatism|June 1, 1996
Clinical utility of bone mass measurements in adults: consensus of an international panel. The Society for Clinical DensitometryP D Miller, S L Bonnick, C J Rosen, et al.
Pageof 12